Balazs Halmos, MD, discussed the potential impact of subcutaneous amivantamab for patients with EGFR -mutated NSCLC. Halmos ...
Personalized dosing strategies may be necessary for biologic therapies, especially fixed-dose options like ustekinumab, due ...
Inhaled corticosteroids pose long-term risks in COPD management, prompting careful screening and potential de-escalation ...
The FDA approved tezepelumab-ekko (TEZSPIRE; AstraZeneca/Amgen) on Friday as an add-on maintenance treatment in patients aged ...
Effective patient counseling is paramount for adherence as patients with obstructive sleep apnea (OSA) start looking to take ...
Therefore, based on their findings, they recommend a comprehensive eye exam for patients living with MG who experience vision ...
Monthly telehealth medication abortion (teleMAB) service requests doubled following the Supreme Court's Dobbs v Jackson Women ...
Combining 177 Lu-PSMA-617 with SOC produced statistically significant rPFS, reducing the risk of radiographic progression or death by 28% (HR 0.72; 95% CI, 0.58-0.90) vs SOC alone in patients with ...
Earlier menopause may increase dementia risk due to its impact on brain aging and cardiac function, necessitating sex-specific dementia prevention strategies. Women experiencing early menopause face a ...
Perioperative enfortumab vedotin plus pembrolizumab demonstrated significant results in a population that represents roughly half of all patients with MIBC.
For oncologists, seeing more young patients also raises the question of what happens after treatment, and this prompted the ...
The FDA has expanded the label for oral semaglutide (Rybelsus; Novo Nordisk) tablets 7 mg and 14 mg to reduce the risk of major adverse cardiovascular events (MACE) in adults with type 2 diabetes who ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback